Indicators

Markets:

News

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound

July 16, 2025

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

July 09, 2025

Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others

July 08, 2025

Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground

June 25, 2025

5 things to know before the stock market opens Tuesday

June 24, 2025

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%

June 23, 2025

Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition

June 11, 2025

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs

May 21, 2025

Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly

May 19, 2025

Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price

May 16, 2025

Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down

May 15, 2025

Why Americans pay so much more for prescription drugs

May 14, 2025

Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance

May 07, 2025

Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat

May 07, 2025

How much a $1,000 investment in Hims & Hers at its IPO would be worth now

May 06, 2025

Hims & Hers brings former Amazon executive into C-suite

May 05, 2025

Cramer's week ahead: Earnings from Disney, Palantir and Uber

May 02, 2025

Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit

May 02, 2025

CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans

May 01, 2025

Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth

April 29, 2025

Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic

April 25, 2025

Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma

April 22, 2025

5 European stocks to watch this earnings season as Trump's tariffs hit

April 22, 2025

Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients

April 17, 2025

CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine

April 14, 2025

Pfizer scraps daily weight loss pill after liver injury in one patient

April 14, 2025

Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback

April 10, 2025

Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

April 04, 2025

The biggest winners and losers in Europe as Trump announces sweeping tariffs

April 03, 2025

Pharma tariff relief likely short-lived with sector-specific duties on the horizon

April 03, 2025

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.